Syndevrx

Financial Services · Biotechnology

Facts

as of Nov 17, 2026

About Company Our Team Investor Science Metabo-oncology Drug Conjugation Angiogenesis Pipeline Clinical trials Patients Media SynDevRx Publications Press Releases and Events Other Related Contact us About Us About SynDevRx We are dedicated to making Metabo-Oncology a new cancer treatment modality.

Legal name
SYNDEVRX INC
Headquarters
Cambridge, United States
Founded
1992
Employees
51-200estimated range
Register numbers
NAME syndevrx inc
Official records
SEC CIK 1455364
Website
syndevrx.com

These are the key facts about Syndevrx on Alion as of Nov 17, 2026. Syndevrx is headquartered in Cambridge, United States. It was founded in 1992.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Legal entity active
SYNDEVRX INC
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
SiteTypeOpen rolesHires most forEngineering
Cambridge United StatesHeadquarters0
Source: office addresses in postings and company registers

Financials

Funding rounds, investors and revenue on record.

$79.2MTotal raised
Debt FinancingLatest round
8Rounds and grants
Money by yearUSD, rounds and grants
2024$35.8M2 records
2020$23.2M1 record
2018$850k1 record
2017$1.5M1 record
2012$16.3M1 record
2010$225k1 record
2009$1.3M1 record
Largest rounds and grants
Sources: funding announcements, grant and company registers

Milestones

Nov 4, 2024
Took on debt financing $6.5M · SEC Form D
Sep 30, 2024
1992
Founded
Each milestone is dated by its source: registers, filings, the press